| ACUTE STROKE MANAGEMENT IN TURKEY: CURRENT SITUATION AND FUTURE PROJECTION | Atilla Özcan ÖZDEMİR, Mehmet Akif TOPÇUOĞLU | 1–13 |
| TIME DEPENDENT CALIBRATION OF HEMIPLEGIA AS A SENSITIVE CLINIMETRIC TOOL FOR OCCLUSION OF M1 SEGMENT OF THE MIDDLE CEREBRAL ARTERY | Sohail ADNAN, Mubasher SHAH, Syed Fahim SHAH, Akhtar ALİ, Fahad NAİM, Muhammad HAMİD | 14–22 |
| ISCHEMIC STROKE IN COVID-19 PATIENTS: SINGLE CENTER, ONE YEAR EXPERIENCE | Hazal SELVİ ÇUBUK, Can ÇUBUK, Taylan ALTIPARMAK | 23–30 |
| THE DIAGNOSTIC AND PROGNOSTIC VALUE OF RED CELL DISTRIBUTION WIDTH (RDW) IN CEREBRAL VENOUS THROMBOSIS | Havva Meltem MUTLUCAN, Murat UÇAR, Zühre KAYA, Aslı AKYOL GÜRSES, Bijen NAZLIEL, Hale Zeynep BATUR ÇAĞLAYAN, İlker ARSLAN | 31–37 |
| EVALUATION OF MECHANICAL THROMBECTOMY RESULTS IN PATIENTS WHO DEVELOPED ACUTE ISCHEMIC STROKE WHILE USING NEW GENERATION ORAL ANTICOAGULANTS | Atilla Özcan ÖZDEMİR, Ezgi SEZER ERYILDIZ, Fergane MEMMEDOVA, Fatma GER AKARSU, Özlem AYKAÇ, Zaur MEHDİYEV, Fatma ALTUNTAŞ KAYA | 38–45 |
| ASSESSMENT OF ACETYLSALICYLIC ACID AND CLOPIDOGREL RESISTANCE RESULTS OF THE PATIENTS WITH SIGNIFICANT STENOSIS ON CAROTID COLOR DOPPLER ULTRASONOGRAPHY | Fatma YILMAZ CAN, Beyza Nur ÇETİN | 46–53 |
| CAPSULAR WARNING SYNDROME | Nihat ŞENGEZE, Vedat Ali YÜREKLİ, Özge TÜRK | 54–58 |
| ACUTE-ONSET HEMIBALLISMUS DUE TO THALAMIC HEMATOMA: A CASE REPORT | Recep BAYDEMİR, Şeyma BENLİ, Murat GÜLTEKİN | 59–62 |
| WHAT HAPPENS WHEN YOU TREAT SEPTIC CEREBRAL EMBOLI WITH INTRAVENOUS THROMBOLYTIC TREATMENT? A CASE REPORT | Ayse GÜLER, Gülsüm SARUHAN, Neşe ÇELEBİSOY, Hadiye ŞİRİN | 63–67 |